Target
Aspartate aminotransferase, cytoplasmic
Ligand
BDBM50607315
Substrate
n/a
Meas. Tech.
ChEMBL_2262599 (CHEMBL5217610)
IC50
>50000±n/a nM
Citation
 Günther, JHillig, RCZimmermann, KKaulfuss, SLemos, CNguyen, DRehwinkel, HHabgood, MLechner, CNeuhaus, RGanzer, UDrewes, MChai, JBouché, L BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe. J Med Chem 65:14366-14390 (2022) [PubMed] 
Target
Name:
Aspartate aminotransferase, cytoplasmic
Synonyms:
2.6.1.1 | 2.6.1.3 | AATC_HUMAN | Aspartate aminotransferase, cytoplasmic | Cysteine aminotransferase, cytoplasmic | Cysteine transaminase, cytoplasmic | GOT1 | Glutamate oxaloacetate transaminase 1 | Transaminase A | cAspAT | cCAT
Type:
PROTEIN
Mol. Mass.:
46249.45
Organism:
Homo sapiens
Description:
ChEMBL_105469
Residue:
413
Sequence:
MAPPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGTGALRIGADFLARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLENAPEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWAIRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPPAQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGMFSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ
  
Inhibitor
Name:
BDBM50607315
Synonyms:
BAY-069
Type:
Small organic molecule
Emp. Form.:
C22H14ClF3N2O3
Mol. Mass.:
446.806
SMILES:
Cc1ccccc1Oc1cc(-n2c(=O)cc([nH]c2=O)C(F)(F)F)c2ccccc2c1Cl |(20.53,-12.27,;19.26,-11.42,;19.36,-9.88,;18.08,-9.03,;16.7,-9.71,;16.59,-11.25,;17.87,-12.1,;17.76,-13.64,;16.38,-14.32,;15.11,-13.47,;13.73,-14.15,;12.45,-13.3,;12.56,-11.76,;13.94,-11.08,;11.28,-10.9,;9.9,-11.59,;9.79,-13.13,;11.07,-13.98,;10.96,-15.52,;8.45,-11.09,;8.55,-9.56,;7.17,-10.24,;7.29,-12.11,;13.62,-15.7,;12.24,-16.38,;12.13,-17.91,;13.41,-18.77,;14.79,-18.09,;14.9,-16.55,;16.28,-15.87,;17.55,-16.72,)|
Structure:
Search PDB for entries with ligand similarity: